Welcome to our November issue! Our cover feature focuses on social media; could making better use of social media platforms boost pharma’s reputation and support marketing efforts? The pharma industry’s reputation is also a focus of our Business article featuring the Association of the British Pharmaceutical Industry. Also in this issue, we cover digital tools for bioprocessing, how to reduce the costs of biosimilars, antibody drug conjugates versus cancer, and Darlene Solomon from Agilent gives her view on the future of bio-innovation. Finally, we sit down with Bernard Pécoul, Executive Director of the Drugs for Neglected Diseases initiative to find out about his career and the work of the DNDi.
December 22, 2021
Despite considerable progress, ocular gene therapy development remains challenging – but an emphasis on more efficient preclinical processes could streamline the route to market for valuable therapies
1 min read
December 3, 2021
Sitting Down With: Bernard Pécoul, Executive Director, DNDi, Geneva, Switzerland
1 min read
November 15, 2021
On-dose authentication technology can help deter counterfeiters, while also helping patients better engage with their medicines
1 min read
November 15, 2021
When it comes to delivering biologic medicines to patients in need, choosing the right packaging partner can make all the difference
1 min read
November 12, 2021
Bringing digital tools and data analytics together will improve success rates in bioprocess operations
1 min read
November 11, 2021
How RNA is making waves in the industry – and leading to new research projects and increased demand for new manufacturing capacities and facility design
1 min read
November 9, 2021
Antibody drug conjugates are starting to transform cancer treatments, so let’s maintain the momentum
1 min read
November 8, 2021
Wanting to win any battle, anywhere, the US military has commissioned a vaccine against the plague
1 min read
November 4, 2021
An industry partnership will put self-amplifying RNA to the test
1 min read
November 1, 2021
Can we use reverse vaccination to manage autoimmune diseases?
1 min read
October 15, 2021
The Association of the British Pharmaceutical Industry (ABPI) recently published an index that tracks UK pharma’s domestic reputation. We spoke with the ABPI’s Director of Reputation, Jill Pearcy, to see if it’s all sunshine and rainbows – or simply suffering.
1 min read
October 14, 2021
With a wealth of sensitive data under its belt, the pharmaceutical industry is ripe for cyberattacks. With the risk of infiltration ever-present (and growing), how can companies protect themselves?
1 min read
October 13, 2021
A drug screening project reveals a welcome surprise: a potential insight into the action of several agents interfering with SARS-CoV-2 assays
1 min read
September 8, 2021
Here’s how the next century of bio-innovation could look – from sequence to therapeutics...
1 min read
